This trial studies the screening of human papillomavirus (HPV)-related oropharyngeal and
uncommon cancers. Learning the relationship between HPV and cancer risk in men who test
positive for HPV antibodies may help doctors to develop early methods of screening for
certain types of cancer, and screening for HPV may help doctors to learn which patients may
be at a higher risk for developing certain types of cancer.